Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

A new drug called lepodisiran may offer hope to millions of people at risk of heart attacks and strokes by targeting a little ...

BioLife Solutions is poised to benefit from the booming cell and gene therapy sector. Read more to see my investment strategy ...

Prudential Financial Inc. increased its holdings in Xenon Pharmaceuticals Inc. (NASDAQ:XENE – Free Report) by 177.7% in the ...

KLP Kapitalforvaltning AS bought a new stake in shares of Agios Pharmaceuticals, Inc. (NASDAQ:AGIO – Free Report) in the ...

We recently published a list of 10 Unstoppable Stocks That Could Double Your Money. In this article, we are going to take a ...

Four of Wall Street's most beloved blue-chip dividend stocks are on sale. They can provide a steady stream of passive income.

Calley Means is advising Kennedy's overhaul of HHS and he doesn't hesitate to lambaste the people he says are profiting from a broken health care system that keeps people sick.

This is CNBC’s coverage of how U.S. trade partners, industries and employers respond to President Donald Trump’s historic tariffs.

The health sector faces significant instability with President Trump's tariff threats targeting Indian pharmaceutical stocks, ...

While manufacturers of FDA-approved injectable pentobarbital are warning states not to use the sedative in executions, some ...

Billionaire entrepreneur and Cost Plus Drugs co-founder Mark Cuban won't have to raise medicine prices, as Trump’s new ...